| Abstrakt: |
SAN DIEGO, March 24, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the appointment of N. Anthony Coles (Tony), M.D. to the company's Board of Directors. Dr. Coles brings nearly 30 years of experience in the healthcare, biotechnology and pharmaceutical industries. Most recently, Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, a global biopharmaceutical company that was acquired by Amgen in October 2013. [ABSTRACT FROM PUBLISHER] |
